Turn Therapeutics Inc. (TTRX): Total Liabilities
$7.48M
As of 2025-12-31
$16.27M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.48M | +235.8% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.23M | n/a | 2026-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $7.48M | +235.8% |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $487.7K | +87.2% |
| Imunon, Inc. (IMNN) | 2025-12-31 | $5.23M | -4.5% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $1.77M | +456.8% |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $2.72M | +42.2% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $361.0K | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $3.38M | -41.0% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $5.03M | +115.6% |
Compare TTRX, ANEB, IMNN, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗